In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes

Journal of Endocrinology

Volumn 204, Issue 1, 2010, Pages 75-84

  Lappas, Martha ^a,b   Mittion, Amberlee ^a   Permezel, Michael ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; CATALASE; CYTOKINE; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; AUTACOID; DRUG DERIVATIVE; OXIDOREDUCTASE;

ADULT; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; OMENTUM; OXIDATIVE STRESS; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; ADIPOSE TISSUE; DRUG EFFECT; GENETICS; METABOLISM; PREGNANCY; SUBCUTANEOUS TISSUE;

ADIPOSE TISSUE; CATALASE; CYTOKINES; DIABETES, GESTATIONAL; DINOPROST; FEMALE; GENE EXPRESSION; GLUTATHIONE REDUCTASE; HUMANS; INFLAMMATION MEDIATORS; OXIDATIVE STRESS; OXIDOREDUCTASES; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS TISSUE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

EID: 73949102011     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0321     Document Type: Article

References (30)

1. Baynes JW 1991 Role of oxidative stress in development of complications in diabetes. Diabetes 40 405-412.
2. Beischer NA, Wein P, Sheedy MT & Steffen B 1996 Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Australian and New Zealand Journal of Obstetrics and Gynaecology 36 239-247.
3. Biri A, Onan A, Devrim E, Babacan F, Kavutcu M & Durak I 2006 Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta 27 327-332.
4. Chaudhari L, Tandon OP, VaneyN & AgarwalN 2003 Lipid peroxidation and antioxidant enzyme in gestational diabetes. Indian Journal of Physiology and Pharmacology 47 441-446.
5. Coughlan MT, Vervaart PP, Permezel M, Georgiou HM & Rice GE 2004a Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 25 78-84.
6. Coughlan MT, Permezel M, Georgiou HM & Rice GE 2004b Repression of oxidant-induced nuclear factor-kB activity mediates placental cytokine responses in gestational diabetes. Journal of Clinical Endocrinology and Metabolism 89 3585-3594.
7. Courtois G & Gilmore TD 2006 Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene 25 6831-6843.
8. Desco MC, Asensi A, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J & Vina J 2002 Xanthine oxidase is involved in free radical production in type 1 diabetes - protection by allopurinol. Diabetes 51 1118-1124.
9. Evans HE, RosenfeldW, Jhaveri R, Conception L & Zabaleta I 1986 Oxidant mediated lung disease in newborn infants. Journal of Free Radicals in Biology and Medicine 2 369-372.
10. Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomeseth K, Wagner OF, Ulm M, Streli C & Ludvik B 1997 Pronounced insulin resistance and inadequate b cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20 1717-1723.
11. Kinalski M, Sledziewski A, Telejko B, Kowalska I, Kretowski A, Zarzycki W & Kinalska I 2001 Lipid peroxidation, antioxidant defence and acid-base status in cord blood at birth: the influence of diabetes. Hormone and Metabolic Research 33 227-231.
12. Lappas M & Rice GE 2007 The role and regulation of the nuclear factor kappa B signalling pathway in human labour. Placenta 28 543-556.
13. Lappas M, Permezel M & Rice GE 2003 N-acetyl-cysteine inhibits phospholipid metabolism, pro-inflammatory cytokine release, protease activity, and nuclear factor-κB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. Journal of Clinical Endocrinology and Metabolism 88 1723-1729.
14. Lappas M, Permezel M & Rice GE 2004 Release of pro-inflammatory cytokines and 8-isoprostane from placenta, adipose tissue and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 89 5627-5633.
15. Lappas M, Permezel M& Rice GE 2005 Leptin and adiponectin stimulate the release of pro-inflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via NF-κB, PPAR-γ and ERK 1/2. Endocrinology 146 3334-3342.
16. Lappas M, Yee K, Permezel M & Rice GE 2006 Lipopolysaccharide and TNF-a activate the nuclear factor kappa B pathway in the human placental JEG-3 cells. Placenta 27 568-575.
17. Lee BR & Um HD 1999 Hydrogen peroxide suppresses U937 cell death by two different mechanisms depending on its concentration. Experimental Cell Research 248 430-438.
18. Lee AJ, Hiscock RJ, Wein P, Walker SP & Permezel M 2007 GDM: clinical predictors and long-term risk of developing type 2 diabetes. Diabetes Care 30 878-883.
19. -ΔΔCt method. Methods 25 402-408.
20. Lu D, Maulik N, Moraru II, Kreutzer DL & Das DK 1993 Molecular adaptation of vascular endothelial cells to oxidative stress. American Journal of Physiology 264 C715-C722.
21. Madazl R, Tuten A, Calay Z, Uzun H, Uludag S & Ocak V 2008 The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecologic and Obstetric Investigation 65 227-232.
22. Maritim AC, Sanders RA & Watkins JB 2003 Diabetes, oxidative stress, and antioxidants: a review. Journal of Biochemical and Molecular Toxicology 17 24-38.
23. Myatt L, Kossenjans W, Sahay R, Eis A & Brockman D 2000 Oxidative stress causes vascular dysfunction in the placenta. Journal of Maternal Fetal and Neonatal Medicine 9 79-82.
24. Peuchant E, Brun J-L, Rigalleau V, Dubourg L, Thomas M-J, Daniel J-Y, Leng J-J & Gin H 2004 Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clinical Biochemistry 37 293-298.
25. Pustovrh C, Jawerbaum A, Sinner D, Pesaresi M, Baier M, Micone P, Gimeno M & Gonzalez ET 2000 Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reproduction, Fertility, and Development 12 269-275.
26. Reti NG, Lappas M, Huppertz B, Riley C, Wlodek ME, Henschke P, Permezel M & Rice GE 2007 Effect of high oxygen on placental function in short-term explant cultures. Cell and Tissue Research 328 607-616.
27. Singh U, Devaraj S & Jialal I 2005 Vitamin E, oxidative stress, and inflammation. Annual Review of Nutrition 25 151-174.
28. Trocino RA, Akazawa S, Ishibashi M, Matsumoto K, Matsuo H, YamamotoH, Goto S, Urata Y, Kondo T & Nagataki S 1995 Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44 992-998.
29. West IC 2000 Radicals and oxidative stress in diabetes. Diabetic Medicine 17 171-180.
30. Wiese AG, Pacifici RE & Davies KJA 1995 Transient adaptation to oxidative stress in mammalian cells. Archives of Biochemistry and Biophysics 318 231-240.